$5.55M Teva, Granules & Heritage Metformin NDMA Settlement, Do You Qualify for a Payment? File Your Claim by July 10

The Teva, Granules, and Heritage metformin settlement is a $5,550,000 class action resolution where eligible consumers who purchased generic metformin between July 20, 2015 and June 2, 2020 can receive a pro-rata payment by filing a claim before July 10, 2026. Teva Pharmaceuticals agreed to pay $3,000,000, while Granules USA and Heritage Pharmaceuticals agreed to pay $2,550,000, to settle claims that their metformin products were contaminated with NDMA — a probable human carcinogen — and did not meet FDA standards. All three companies deny wrongdoing.

Quick Facts — Teva, Granules & Heritage Metformin Settlement

Field	Detail
Settlement Amount	$5,550,000 total ($3M Teva + $2.55M Granules/Heritage)
Claim Deadline	July 10, 2026
Who Qualifies	U.S. residents who purchased generic metformin for personal use from Teva, Granules, or Heritage between July 20, 2015 and June 2, 2020
Payout Per Person	TBD — determined pro-rata based on purchase amounts and total valid claims filed
Proof Required	Yes — pharmacy records, doctor’s note, EOB, receipts, or credit card statements
Settlement Status	Preliminarily Approved — pending final court approval August 12, 2026
Administrator	A.B. Data, Ltd.
Official Website	www.inremetforminsettlement.com
Last Updated	May 19, 2026

Current Status and What Comes Next

• Judge Madeline C. Arleo of the U.S. District Court for the District of New Jersey granted preliminary approval in April 2026. The settlements are not yet final.
• The final approval hearing is scheduled for August 12, 2026 at 10:00 a.m. via Microsoft Teams. If you want to speak at the hearing, you must submit your intent to appear by July 24, 2026.
• Claims, opt-outs, and objections are all due by July 10, 2026. Payments will only go out after the court grants final approval and any appeals are resolved.

What Is the Metformin Lawsuit About? In Re Metformin Marketing and Sales Practices Litigation, No. 2:20-cv-2324

Metformin is one of the most widely prescribed drugs in the country. Millions of Americans with type 2 diabetes take it every day to manage blood sugar — so when contamination concerns emerged, the impact was widespread.

The lawsuit, filed in the U.S. District Court for the District of New Jersey, alleges that Teva Pharmaceuticals, Granules USA, and Heritage Pharmaceuticals (doing business as Avet Pharmaceuticals) sold generic metformin products contaminated with N-nitrosodimethylamine, or NDMA. Both the EPA and FDA classify NDMA as a probable human carcinogen. The lawsuit claims the defendants falsely advertised their products as equivalent to brand-name Glucophage and Glucophage XR when they allegedly fell short of FDA manufacturing standards — meaning consumers paid for a drug they would not have purchased had they known the truth.

Related article: KFC $28.8 Million Rest Break Settlement, Did You Work There? Here Is How to Register Before the Deadline Of 4pm, 26 June

The case does not involve personal injury or wrongful death claims. This is purely an economic loss claim — if you paid for contaminated metformin, the plaintiffs say you paid for something that was not what it was advertised to be. CVS Pharmacy is also named in the settlements for allegedly selling the affected products. The lawsuit continues against Amneal Pharmaceuticals and Walmart, who have not settled. For a broader overview of how consumer drug litigation works, see our guide to class action lawsuits and consumer rights at AllAboutLawyer.com.

Do You Qualify for the Metformin NDMA Settlement?

If you’re asking “do I qualify for the metformin settlement,” the core question is simple: did you pay out of pocket for generic metformin between July 2015 and June 2020?

You may qualify if:

• You are a U.S. resident (including territories and possessions)
• You purchased a generic metformin-containing drug for personal or household use between July 20, 2015 and June 2, 2020
• The metformin was manufactured, distributed, or sold by Teva, Actavis, Granules, or Heritage (including CVS-sold versions of these products)
• You paid any portion of the cost — even a co-pay counts

You do NOT qualify if:

• You purchased metformin for resale (not personal use)
• You purchased directly from Teva, Granules, or Heritage as a manufacturer (not retail)
• You are a fully insured health plan, pharmaceutical benefit manager, or federal government entity
• You already excluded yourself from both settlements

Not sure which manufacturer made your metformin? Check your pharmacy records or call your insurance company. The label on your prescription bottle should identify the manufacturer.

This is one of the situations where a consumer rights lawyer or free legal consultation can clarify your specific situation, particularly if you are a third-party payor filing on behalf of a plan.

How Much Can You Get from the Metformin Settlement?

The exact payout per person is not yet set — and that is not unusual for this type of settlement.

After taxes, administration costs (up to $500,000), attorneys’ fees (up to 34% of the fund), and class representative service awards (up to $3,500 each), the remaining funds go to eligible claimants on a pro-rata basis. That means your share depends on how much you spent on metformin during the class period compared to all other valid claimants.

The more prescriptions you bought, and the more you paid out of pocket, the larger your proportional share. The final number also depends on how many people file valid claims — the more people who claim, the smaller each individual payment. There is no minimum payout guaranteed. If funds remain after all distributions, they go to a court-approved nonprofit — not back to the defendants.

How to File Your Metformin Settlement Claim

Filing is free and takes roughly 10–15 minutes online. Here is exactly how to do it:

1. Go to www.inremetforminsettlement.com and click “File a Claim”
2. Fill out Section A — your name, address, phone, and email
3. Complete Section B — confirm you qualify as a consumer class member
4. Fill in Section C — enter the total number of metformin prescriptions you purchased between July 20, 2015 and June 2, 2020, and the total amount you paid out of pocket
5. Upload your proof — pharmacy printout, EOB from your insurer, doctor’s records, receipts, or credit card statements showing at least one purchase
6. Sign and submit — you are certifying under penalty of perjury that the information is accurate

You can also mail a completed paper form to: In re Metformin Marketing and Sales Practices Litigation, c/o A.B. Data, Ltd., P.O. Box 173012, Milwaukee, WI 53217 — postmarked no later than July 10, 2026.

Estimated time to complete: 10–15 minutes online.

Metformin Settlement Key Deadlines

Milestone	Date
Preliminary Approval	April 28, 2026
Claim Filing Deadline	July 10, 2026
Opt-Out Deadline	July 10, 2026
Objection Deadline	July 10, 2026
Intent to Appear Deadline	July 24, 2026
Final Approval Hearing	August 12, 2026 at 10:00 a.m. (Microsoft Teams)
Expected Payment Date	TBD — after final court approval and any appeals are resolved

Frequently Asked Questions

Is there a class action settlement against Teva for metformin? 

Yes. Teva agreed to pay $3,000,000 as part of In Re Metformin Marketing and Sales Practices Litigation, No. 2:20-cv-2324, in the U.S. District Court for the District of New Jersey. Granules and Heritage separately agreed to $2,550,000. Both settlements are pending final court approval at the August 12, 2026 hearing.

Do I need a lawyer to file a metformin settlement claim?

 No. You can file directly at inremetforminsettlement.com for free. The court has already appointed Co-Lead Counsel from firms including Carella Byrne Cecchi Brody Agnello, P.C. and Kanner & Whiteley to represent all class members at no cost to you.

How much will I get from the metformin NDMA settlement? 

The individual payout is TBD — it depends on your total out-of-pocket spending on metformin during the class period, the total number of valid claims, and deductions for fees and costs. Payments are calculated pro-rata, so the more you spent, the larger your share.

When will I receive my payment?

 Payments will only go out after Judge Arleo grants final approval and any appeals are resolved. The final approval hearing is August 12, 2026. If no appeals are filed, payments could begin in late 2026 or early 2027. Patience is required.

What if I missed the claim deadline? 

The July 10, 2026 deadline is firm. If you miss it, you will not receive a payment from these settlements, and you will still be bound by the settlement terms — meaning you cannot sue Teva, Granules, or Heritage separately for the same claims. If you want to preserve your right to sue independently, you must submit an opt-out request by July 10, 2026.

Will this settlement payment affect my taxes? 

Possibly. Payments that compensate you for economic loss — like paying for a drug that did not meet quality standards — may be treated as taxable income depending on your individual situation. Consult a tax professional after you receive your payment for advice specific to your circumstances.

What proof do I need to file a claim?

 You need at least one document showing you purchased generic metformin between July 20, 2015 and June 2, 2020. Acceptable documents include pharmacy records, an explanation of benefits (EOB) from your insurer, a doctor’s note with prescription history, receipts, or credit card statements. If you submit without documentation, the administrator may ask for it later.

Is the metformin settlement legitimate?

 Yes. The settlements were authorized by the U.S. District Court for the District of New Jersey and preliminarily approved by Judge Madeline C. Arleo on April 28, 2026. The claims administrator is A.B. Data, Ltd., a nationally recognized settlement administrator. Filing is always free — never pay anyone to submit your claim.

Sources & References

• Official Settlement Notice: inremetforminsettlement.com
• Official Claim Form: claimform.inremetforminsettlement.com
• Court Docket: In Re Metformin Marketing and Sales Practices Litigation, No. 2:20-cv-2324, U.S. District Court for the District of New Jersey
• Preliminary Approval Announcement: Kanner & Whiteley, L.L.C., April 28, 2026

Prepared by the AllAboutLawyer.com Editorial Team and reviewed for factual accuracy against official court records and the settlement administrator website on May 19, 2026. Last Updated: May 19, 2026

Disclaimer: This article is for informational purposes only and does not constitute legal advice. Legal claims and outcomes depend on specific facts and applicable law. For advice regarding a particular situation, consult a qualified attorney.